Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral and AAV Gene Therapies at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Rocket Pharmaceuticals, Inc. , a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders with high unmet need, today...
Bruxelles Capitale Enfermedades Raras Jonathan Schwartz Kinnari Patel Medioambientalesy Tecnol Bitha Narayanan
Source: marketscreener.com